Cabozantinib in High Grade Neuroendocrine Neoplasms
Clinical trial NCT04412629 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04412629
- Sponsor
- Washington University School of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-24
- Primary completion
- 2026-09-30
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.